Patents by Inventor Michael Borns

Michael Borns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132867
    Abstract: The disclosure provides compositions comprising novel adenosine base editors (e.g., ABE8) that have increased efficiency and methods of using these adenosine deaminase variants for editing a target sequence.
    Type: Application
    Filed: October 13, 2023
    Publication date: April 25, 2024
    Applicant: Beam Therapeutics Inc.
    Inventors: Nicole GAUDELLI, Michael PACKER, Ian SLAYMAKER, Yi YU, Bernd ZETSCHE, Jason Michael GEHRKE, Natalie PETROSSIAN, Angelica MESSANA, Yvonne ARATYN, Francine GREGOIRE, Genesis LUNG, Shaunna BERKOVITCH, David A. BORN, Seung-Joo LEE
  • Patent number: 10240196
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: March 26, 2019
    Assignee: AGILENT TECHNOLOGIES, INC.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Patent number: 10093962
    Abstract: The present invention relates to compositions and methods of target enrichment or selection of nucleic acids using hybridization, which can be used in, e.g., next-generation sequencing.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: October 9, 2018
    Assignee: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Publication number: 20170342483
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Application
    Filed: May 27, 2016
    Publication date: November 30, 2017
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen
  • Patent number: 9587268
    Abstract: The present invention relates to compositions and methods of target enrichment or selection of nucleic acids using hybridization, which can be used in, e.g., next-generation sequencing.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: March 7, 2017
    Assignee: Agilent Technologies Inc.
    Inventor: Michael Borns
  • Publication number: 20160017405
    Abstract: The present invention relates to compositions and methods of target enrichment or selection of nucleic acids using hybridization, which can be used in, e.g., next-generation sequencing.
    Type: Application
    Filed: September 29, 2015
    Publication date: January 21, 2016
    Applicant: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Patent number: 9181534
    Abstract: The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 5?-3? exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA synthesis using the subject compositions of the invention.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: November 10, 2015
    Assignee: Agilent Technologies Inc.
    Inventors: Holly Hogrefe, Michael Borns, Joseph A. Sorge
  • Publication number: 20150211047
    Abstract: The present invention relates to compositions and methods of target enrichment or selection of nucleic acids using hybridization, which can be used in, e.g., next-generation sequencing.
    Type: Application
    Filed: January 29, 2014
    Publication date: July 30, 2015
    Applicant: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Patent number: 9040276
    Abstract: The invention relates to compositions and methods directed to chimeric DNA polymerases, which comprise a mutated DNA binding polypeptide domain and a mutated or wild-type DNA polymerase polypeptide domain.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: May 26, 2015
    Assignee: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Patent number: 8883454
    Abstract: The present invention discloses methods of using DNA polymerase fusions at high pH in PCR, DNA sequencing and mutagenesis protocols.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: November 11, 2014
    Assignee: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Publication number: 20120003713
    Abstract: The invention provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases. Included within the aspects of the invention are methods for identifying compositions with a polymerase enhancing activity, methods for purifying and using these compositions, and specific extracts, proteins, and complexes that function to enhance polymerase activity. As an example, specifically described is nucleotide and amino acid sequence information for a Pyrococcus furiosus PEF (P45), which was used to produce a recombinant PEF.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 5, 2012
    Applicant: AGILENT TECHNOLOGIES, INC.
    Inventors: Connie Hansen, Holly Hogrefe, Michael Borns, Michael Muhich
  • Patent number: 8014279
    Abstract: In one aspect, a method to schedule network communications includes transmitting a node identification associated with a first node joining a network over a first portion of control timeslots based on a first probability, detecting nodes in the network using a second portion of the control timeslots and receiving acknowledgments from at least one of the nodes in the network. The method also includes that if a ratio of a number of acknowledgments received to a number of the nodes in the network detected is greater than a predetermined percentage: transmitting control data over the first portion of the control timeslots based on a second probability associated with a number of the nodes detected and transmitting data over the second portion of the control timeslots based on a network schedule.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: September 6, 2011
    Assignee: Raytheon Company
    Inventors: Sung Park, Darryn A. Johnnie, Michael A. Born, Colleen M. Touchard, Keith C. Buerger, Tyler J. Ulinskas
  • Patent number: 7960157
    Abstract: The present invention discloses novel blends of chimeric and non-chimeric thermostable DNA polymerases for use in PCR, DNA sequencing and mutagenesis protocols. The invention allows for PCR reactions with shorter extension times that will facilitate PCR amplification of genomic DNA templates and improve the efficacy of long PCR.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: June 14, 2011
    Assignee: Agilent Technologies, Inc.
    Inventor: Michael Borns
  • Patent number: 7943358
    Abstract: The invention provides novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases. Included within the aspects of the invention are methods for identifying compositions with a polymerase enhancing activity, methods for purifying and using these compositions, and specific extracts, proteins, and complexes that function to enhance polymerase activity. As an example, specifically described is nucleotide and amino acid sequence information for a Pyrococcus furiousus PEF (P45), which was used to produce a recombinant PEF.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: May 17, 2011
    Assignee: Agilent Technologies, Inc.
    Inventors: Connie J. Hansen, Holly Hogrefe, Michael Borns, Michael Muhich
  • Patent number: 7939645
    Abstract: The invention relates to compositions, methods, and kits for nucleic acid replication, including polymerase chain reaction (PCR) and mutagenesis reactions. A buffer composition is provided which allows higher concentrations of DNA polymerase to be used, resulting in greater yield of amplified product and faster reaction kinetics.
    Type: Grant
    Filed: January 8, 2007
    Date of Patent: May 10, 2011
    Assignee: Agilent Technologies, Inc
    Inventor: Michael Borns
  • Patent number: 7932070
    Abstract: The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 3?-5? exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA synthesis using the subject compositions of the invention.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: April 26, 2011
    Assignee: Agilent Technologies, Inc.
    Inventors: Holly Hogrefe, Michael Borns, Joseph A. Sorge
  • Publication number: 20100173365
    Abstract: The present invention discloses methods of using DNA polymerase fusions at high pH in PCR, DNA sequencing and mutagenesis protocols.
    Type: Application
    Filed: December 23, 2009
    Publication date: July 8, 2010
    Inventor: Michael Borns
  • Patent number: 7704712
    Abstract: The present invention discloses methods of using DNA polymerase fusions at high pH in PCR, DNA sequencing and mutagenesis protocols.
    Type: Grant
    Filed: March 19, 2004
    Date of Patent: April 27, 2010
    Assignee: Stratagene California
    Inventor: Michael Borns
  • Patent number: 7659100
    Abstract: The present invention discloses methods of using DNA polymerase fusions at high pH in PCR, DNA sequencing and mutagenesis protocols.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: February 9, 2010
    Assignee: Stratagene California
    Inventor: Michael Borns
  • Patent number: RE49207
    Abstract: Provided herein, among other things, are a variety of methods for transposase-mediated tagging and amplification of short DNA fragments, e.g., between about 150 bp and 1.5 Kb in length. In some aspects, the method includes tagging the DNA fragments with a first primer sequence using barcoded transposases followed by a primer extension reaction to introduce a second primer sequence, e.g., using random or gene-specific primers. Kits for performing this method are also provided.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: September 13, 2022
    Assignee: Agilent Technologies, Inc.
    Inventors: Bahram Arezi, Michael Borns, Holly Hogrefe, Connie Hansen